See What HealthDay Can Do For You
Contact Us

Prompt Aggressive BP Management Encouraged

Systolic reading of 150 should prompt immediate action to prevent poor outcomes, researchers say

THURSDAY, Feb. 5, 2015 (HealthDay News) -- Patients with systolic blood pressure higher than 150 mm Hg face increased risks without aggressive drug treatment started within a month and a half, according to research findings published Feb. 5 in The BMJ.

Alexander Turchin, M.D., director of informatics research in the division of endocrinology at Brigham and Women's Hospital in Boston, and colleagues examined the medical records of 88,756 British patients with hypertension to pinpoint the precise blood pressure level and critical time points at which treatment was tied to a decrease in the risk of hypertension-related death.

In patients with systolic blood pressures between 130 and 150 mm Hg, the research team did not detect an increase in risk, but above the 150 threshold, the team observed progressively greater risk. The study authors also discovered that delaying the intensification of treatment by more than 1.4 months after a blood pressure rise past 150 mm Hg increased a person's risk of heart attack, stroke or early death. In addition, the research team behind the new study found that when patients received a reassessment of blood pressure levels more than 2.7 months after doctors stepped up treatment, their risk of early death also increased.

"There have been many studies that have looked at what the blood pressure threshold should be," Turchin told HealthDay. "Where the American guidelines are currently silent is how quickly we need to respond, and they are silent because there are no data in that area."

Full Text

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.